Agios Pharmaceuticals (AGIO) Q2 2024 Earnings

2MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-1.72
-1.63
-1.54
-1.45

Details

Expected EPS
-1.64
Actual EPS
-1.45
Surprise EPS
0.19
Surprise Percent
+11.59%

Description

Agios Pharmaceuticals (AGIO) has reported earnings of -1.45 per share for Q2 2024.

0 Comments

Share your thoughts